Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance


Por: Martinez-Balibrea, E, Martinez-Cardus, A, Gines, A, de Porras, VR, Moutinho, C, Layos, L, Manzano, JL, Buges, C, Bystrup, S, Esteller, M and Abad, A

Publicada: 1 ago 2015
Resumen:
Oxaliplatin was the first platinum drug with proven activity against colorectal tumors, becoming a standard in the management of this malignancy. It is also considered for the treatment of pancreatic and gastric cancers. However, a major reason for treatment failure still is the existence of tumor intrinsic or acquired resistance. Consequently, it is important to understand the molecular mechanisms underlying the appearance of this phenomenon to find ways of circumventing it and to improve and optimize treatments. This review will be focused on recent discoveries about oxaliplatin tumor-related resistance mechanisms, including alterations in transport, detoxification, DNA damage response and repair, cell death (apoptotic and nonapoptotic), and epigenetic mechanisms.

Filiaciones:
:
 Hosp Badalona Germans Trias & Pujol, Med Oncol Serv, ICO, Barcelona 08916, Spain

 Inst Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Badalona, Catalonia, Spain

Martinez-Cardus, A:
 Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain

Gines, A:
 Inst Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Badalona, Catalonia, Spain

:
 Inst Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Badalona, Catalonia, Spain

Moutinho, C:
 Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain

:
 Hosp Badalona Germans Trias & Pujol, Med Oncol Serv, ICO, Barcelona 08916, Spain

:
 Hosp Badalona Germans Trias & Pujol, Med Oncol Serv, ICO, Barcelona 08916, Spain

:
 Inst Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Badalona, Catalonia, Spain

Esteller, M:
 Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain

 Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Catalonia, Spain

 ICREA, Barcelona, Catalonia, Spain

Abad, A:
 Hosp Badalona Germans Trias & Pujol, Med Oncol Serv, ICO, Barcelona 08916, Spain

 Inst Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Badalona, Catalonia, Spain

 Hosp CIMA Sanitas, Oncol Unit, Barcelona, Catalonia, Spain
ISSN: 15357163





Molecular Cancer Therapeutics
Editorial
American Association for Cancer Research, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA, Estados Unidos America
Tipo de documento: Review
Volumen: 14 Número: 8
Páginas: 1767-1776
WOS Id: 000359324600001
ID de PubMed: 26184483

MÉTRICAS